Clinical Study Results
Research Sponsor: AstraZeneca KK
Drug Studied: Sodium zirconium cyclosilicate, also called ZS
Study Title: A study to learn how safe ZS is for Japanese participants with high
levels of potassium in their blood
Thank you!
Thank you to the participants who took part in the clinical study for the study drug sodium
zirconium cyclosilicate, also called ZS. All of the participants helped researchers learn
more about ZS to help people with high levels of potassium in their blood. This condition
is also called hyperkalemia.
AstraZeneca KK sponsored this study and thinks it is important to share the results of
the study with the participants and the public. An independent non-profit organization
called CISCRP helped prepare this summary of the study results. We hope it helps the
participants understand and feel proud of their important role in medical research.
If you participated in the study and have questions about the results, please speak with
the doctor or staff at your study site.
What is happening with the study now?
The participants were in the study for up to about 1 year, but the entire study took about
2 years to finish. The study started in September 2017 and ended in July 2019.
The study included 150 participants in Japan.
The sponsor reviewed the data collected when the study ended and created a report of
the results. This is a summary of that report.
1